A critical step in the development of a solid tumor is the transition of a dormant or slowly growing avascular tumor into a rapidly growing metastatic vascularized tumor. This process of neovascularization depends on the ability of capillary endothelial cells to complete the processes of hydrolysis of basement membrane around pre-existing vessels, migration toward the tumor stimulus, cell proliferation, and the formation of closed vascular channels. We have succeeded in culturing capillary endothelial cells and have used them to develop in vitro assays for the cellular components of the vascular process. The isolation and identification of these cells have been greatly aided by the use of fluorescently labeled acetyl low-density lipoprotein which is selectively taken up by endothelial cells and macrophages. After internalization of this probe, the endothelial cells can be selected and isolated by use of a fluorescence-activated cell sorter. In vitro assays employing capillary endothelial cells have been of use in the identification and isolation of tumor-derived stimulators of neovascularization, and they have also been used for the detection of such factors in biological fluids from tumor-bearing individuals. In the next phase of this project, we will attempt to more fully understand the factors that control growth, migration, and adhesion of capillary endothelial cells by utilizing assays that can distinguish the directional, nondirectional, and adhesive components of endothelial cell motility. We also plan to explore the complex interactions between capillary endothelial cells and other motile cells such as mast cells and eosinophils that may release factors that modulate the rate and direction of new capillary growth. (J)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037393-04
Application #
3175263
Study Section
Cognition and Perception Study Section (CP)
Project Start
1983-07-01
Project End
1988-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
Xu, Yingjie; Yang, Wen; Shi, Jinjun et al. (2016) Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein. J Mol Cell Biol 8:282-5
Zhu, Xi; Xu, Yingjie; Solis, Luisa M et al. (2015) Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment. Proc Natl Acad Sci U S A 112:7779-84
Bielenberg, Diane R; Zetter, Bruce R (2015) The Contribution of Angiogenesis to the Process of Metastasis. Cancer J 21:267-73
Islam, Mohammad Ariful; Reesor, Emma K G; Xu, Yingjie et al. (2015) Biomaterials for mRNA delivery. Biomater Sci 3:1519-33
Shi, Jinjun; Xu, Yingjie; Xu, Xiaoyang et al. (2014) Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing. Nanomedicine 10:897-900
Banyard, Jacqueline; Chung, Ivy; Migliozzi, Matthew et al. (2014) Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer. BMC Cancer 14:387
Banyard, Jacqueline; Chung, Ivy; Wilson, Arianne M et al. (2013) Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model. Sci Rep 3:3151
Olsen, Rachelle R; Chung, Ivy; Zetter, Bruce R (2012) Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo. Amino Acids 42:549-58
Spivey, K A; Chung, I; Banyard, J et al. (2012) A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis. Oncogene 31:2362-72
Olsen, Rachelle R; Zetter, Bruce R (2011) Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer. Mol Cancer Res 9:1285-93

Showing the most recent 10 out of 58 publications